<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01988558</url>
  </required_header>
  <id_info>
    <org_study_id>LA-001-IL</org_study_id>
    <nct_id>NCT01988558</nct_id>
  </id_info>
  <brief_title>A Phase I/II to Assess Safety, Tolerability and Efficacy of DL-lactic Acid Syrup in Children With Recurrent Tonsillitis</brief_title>
  <official_title>A Phase I/II, Randomized, Double Blind, Placebo-controlled Study to Assess the Safety, Tolerability and Efficacy of DL-lactic Acid Syrup (Tonsitin) in Children With Recurrent Tonsillitis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yali Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yali Pharmaceuticals</source>
  <brief_summary>
    <textblock>
      The study objectives are to evaluate Tonsitinâ„¢ (10% Lactic Acid) safety, tolerability and
      preliminary efficacy, as a potent treatment for Recurrent Tonsillitis in children.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety evaluation - Number of participants with adverse events</measure>
    <time_frame>At 90 days post treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tonsil Size</measure>
    <time_frame>Chnge from baseline at 6 months post treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Tonsillitis episodes</measure>
    <time_frame>Chnge in medical history number of recurrent Tonsillitis episodes within 6 months post treatment</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>QOL Questionnaire</measure>
    <time_frame>Chnge from baseline at 90 days post treatment</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Recurrent Tonsillitis in Children</condition>
  <arm_group>
    <arm_group_label>Treated Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Children diagnosed as suffering from recurrent Tonsillitis (at least 4 episodes per year) to receive DL-Lactic acid syrup twice a day for a month.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>DL - Lactic Acid</intervention_name>
    <description>Treated group to receive DL - Lactic Acid Syrup (Raspberry flavored)</description>
    <arm_group_label>Treated Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Raspberry flavored syrup</intervention_name>
    <description>Placebo group to receive Raspberry flavored Syrup</description>
    <arm_group_label>Placebo Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children at the ages of 5-16.

          -  Patient is suffering from recurrent documented sore throat with at least 4 tonsillitis
             episodes during the preceding year (at least one verified by culture or rapid antigen
             testing for Streptococcus A).

          -  Patient with clinical presentation of irregular tonsils.

          -  Tonsils size graded between 2.5-4.

          -  Clinical diagnosis of bacterial known in recurrent pharyngeal-tonsillitis.

          -  Patient is willing to participate in the study and adhere to the study protocol

          -  Patient's guardian and/or Patient have signed informed consent.

        Exclusion Criteria:

          -  Clinical diagnosis of acute tonsillitis/pharyngitis caused by Streptococcus pyogenes
             (Positive RSAT or microbial culture).

          -  Subjects who are known as Streptococcus pyogenes carriers

          -  Subject's requiring any other medication (topical or systemic) that may affect the
             course of the disease during the study period (e.g. antibiotics, sedating
             antihistamines), and/or did not completed 14 days from end of antibiotics treatment.

          -  Subjects with known hypersensitivity to lactose.

          -  Subject is suffering from peritonsillar abscess.

          -  Subject suffers from an active peptic ulcer

          -  Subjects who are suffering from any concomitant disease which in the judgment of the
             investigator will interfere with the conduct or interpretation of the study results.

          -  Subject is currently participating in another clinical study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mati Berkovitz, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>MOH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clalit Health Services, Pediatric Community Ambulatory Clinic</name>
      <address>
        <city>Petach Tikva</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clalit Health Services, Pediatric Community Ambulatory Ganei Hadar clinic</name>
      <address>
        <city>Petach Tikva</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Assaf Harofeh Medical Center</name>
      <address>
        <city>Tzrifin</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 3, 2013</study_first_submitted>
  <study_first_submitted_qc>November 11, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2013</study_first_posted>
  <last_update_submitted>October 6, 2016</last_update_submitted>
  <last_update_submitted_qc>October 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Recurrent Tonsillitis</keyword>
  <keyword>Streptococcus A</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tonsillitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

